A Comparative Analysis of COVID-19 Vaccines Based on over 580,000 Cases from the Vaccination Adverse Event Reporting System.

Kathleen GalloAndrean Goede Cameron Mura Renata AbelBarbara MoahamedSaskia Preissner Susanne Nahles Max Heiland Philip E Bourne Filippo De BraudMichael Mallach

Published in: Vaccines (2022)

Any conclusions from such a retrospective, real-world data analysis must be drawn cautiously, and should be confirmed by prospective double-blinded clinical trials. In addition, we emphasize that the adverse events reported here are not specific side effects of COVID vaccines, and the significant, well-established benefits of COVID-19 vaccination outweigh the potential complications surveyed here.

Keyphrases

coronavirus disease
sars cov
data analysis
clinical trial
adverse drug
emergency department
risk factors
risk assessment
human health
phase iii